AusBiotech has announced a major change that will bring its three flagship conferences together as a single, connected week on the Gold Coast in October 2026.
The move will combine AusMedtech, the AusBiotech International Conference and AusBiotech Invest into a unified experience while ensuring each event keeps its own identity, audience and purpose.
Under the new arrangement, AusMedtech will remain the dedicated forum for Australia’s medtech sector, and AusBiotech Invest will continue as a standalone investment-focused event with its own venue and ticketing.
The AusBiotech International Conference and AusMedtech will share a program, so delegates with a single ticket can move across sessions and engage more broadly across the life sciences ecosystem.
AusBiotech says the decision follows extensive feedback from members, investors, partners and international stakeholders and aims to create a large, scalable week of conferences, exhibitions, partnered events, networking, business partnering and investment engagements designed to cater for the entire life sciences ecosystem.
The organisation has already confirmed a strategic partnership with Tenmile, which will bring its Focal Point and HealthTech Muster events into Australia’s Biggest Week in Biotech.
AusBiotech CEO Rebekah Cassidy said, “The traditional approach of separating biotech, medtech, and digital discussions no longer reflects how innovation is actually happening. Many organisations across our sector are already operating across these boundaries every day.”
She added, “As Australia’s life sciences peak body, we believe it is important that our events and conferences evolve to support that future. Australia’s Biggest Week in Biotech will help to create the scale and momentum our sector needs to succeed on a world stage.”
Queensland State Committee Chair Michael Junger of VAXXAS welcomed the Gold Coast location and said, “Queensland biotech is alive with ideas, startups, and new infrastructure. We look forward to having everyone there. This is the moment for any business in the sector of any size to get behind Australia’s life sciences ecosystem.”